» Authors » Nikolaos Pharmakakis

Nikolaos Pharmakakis

Explore the profile of Nikolaos Pharmakakis including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 17
Citations 84
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Rouvas A, Datseris I, Androudi S, Tsilimbaris M, Kabanarou S, Pharmakakis N, et al.
Clin Ophthalmol . 2022 Aug; 16:2579-2593. PMID: 35983162
Purpose: Real-world evidence on short-term outcomes of ranibizumab in wet age-related macular degeneration (wAMD) following inadequate response to aflibercept is scarce. This study aimed to evaluate the functional and anatomic...
2.
Skourtis G, Krontira A, Ntaoula S, Ferlemi A, Zeliou K, Georgakopoulos C, et al.
Rom J Ophthalmol . 2020 Dec; 64(4):394-403. PMID: 33367177
Oxidative stress plays an important role in the pathogenesis of diabetic retinopathy. The aim of the present study was to investigate the effect of Crocus sativus L. styles (saffron) extract...
3.
Aletras A, Trilivas I, Christopoulou M, Drakouli S, Georgakopoulos C, Pharmakakis N
BMC Ophthalmol . 2018 Dec; 18(1):328. PMID: 30563490
Background: Pterygium is a condition characterized by epithelial overgrowth of the cornea, inflammatory cell infiltration and an abnormal extracellular matrix accumulation. Chronic UV exposure is considered as a pathogenic factor...
4.
Assimakopoulou M, Pagoulatos D, Nterma P, Pharmakakis N
Mol Med Rep . 2017 Aug; 16(4):5285-5293. PMID: 28849159
Cannabinoids, as multi‑target mediators, activate cannabinoid receptors and transient receptor potential vanilloid (TRPV) channels. There is evidence to support a functional interaction of cannabinoid receptors and TRPV channels when they...
5.
Makri O, Tsapardoni F, Pagoulatos D, Pharmakakis N, Georgakopoulos C
Clin Exp Ophthalmol . 2017 May; 45(9):867-874. PMID: 28508561
Importance: Intravitreal injections (IVI) are often painful. Background: To evaluate the analgesic effect of diclofenac in patients undergoing IVI. Design: Single-centre, prospective, randomized, triple-arm, placebo-controlled, interventional study in the University...
6.
Plotas P, Makri O, Georgalas I, Pharmakakis N, Vantarakis A, Georgakopoulos C
Semin Ophthalmol . 2016 Aug; 32(6):738-742. PMID: 27487463
Purpose: This prospective, randomized case series study aims to evaluate the efficacy of ofloxacin 0.3% eye drops in eradication of conjunctival bacterial flora in diabetic patients undergoing intravitreal injections (IVI)....
7.
Androudi S, Dastiridou A, Pharmakakis N, Stefaniotou M, Kalogeropoulos C, Symeonidis C, et al.
Adv Ther . 2016 Apr; 33(5):715-26. PMID: 27116423
Purpose: To propose guidelines for the management of patients with wet age-related macular degeneration (wAMD), taking into account the results of large multicenter studies and clinical experience of retina experts....
8.
Pagoulatos D, Pharmakakis N, Lakoumentas J, Assimakopoulou M
Mol Vis . 2014 Apr; 20:441-57. PMID: 24715760
Purpose: Εnhanced expression of transcription factor hypoxia inducible factor HIF-1α is known to play a critical role in the modulation of cell metabolism and survival pathways as well as having...
9.
Havvas I, Marioli D, Deli A, Zarkadis I, Pharmakakis N
Eur J Ophthalmol . 2014 Feb; 24(5):751-60. PMID: 24519512
Purpose: To elucidate whether polymorphisms of C2, C3, and CFB genes are major genetic determinants of age-related macular degeneration (AMD) in a Greek population. Methods: This was a case-control association...
10.
Rouvas A, Nikita E, Markomichelakis N, Theodossiadis P, Pharmakakis N
J Ophthalmic Inflamm Infect . 2013 Mar; 3(1):21. PMID: 23514018
Background: The purpose of the study is to describe the clinical course and treatment of idiopathic retinitis, vasculitis, aneurysms and neuroretinitis. The study utilized non-randomized, retrospective and interventional case series....